Sign in
4/A

Changes in Ownership

Milestone Pharmaceuticals Inc. Filed Acc 0001771207-26-000005

Options or other derivatives

  • Chief Commercial Officer acquired 204,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Muller Lorenz Chief Commercial Officer 2026-02-02 Grant or award · Employee Stock Option (right to buy) +204,000 204,000 D: show line 1 in the form
Loading xslF345X05/form4a-02052026_040210.xml…